Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic

Laboratory Investigation

Volumn 76, Issue 4, 1997, Pages 517-531

  Ziche, Marina ^a   Maglione, Domenico ^b   Ribatti, Domenico ^c   Morbidelli, Lucia ^a   Lago, Carmine T ^d   Battisti, Mauro ^b   Paoletti, Iole ^d   Barra, Adriano ^d   Tucci, Marina ^b   Parise, Giuliano ^d   Vincenti, Valeria ^d   Granger, Harris J ^f   Viglietto, Giuseppe ^e   Persico, M Graziella ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Geymonat SpA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GROWTH FACTOR; MESSENGER RNA; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CHORIOALLANTOIS; CONTROLLED STUDY; GLYCOPROTEIN SYNTHESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; PLACENTA; PRIORITY JOURNAL; PROTEIN PURIFICATION; RABBIT;

ALLANTOIS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CATTLE; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CHEMOTACTIC FACTORS; CHEMOTAXIS; CHICK EMBRYO; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; RABBITS; RECOMBINANT PROTEINS;

EID: 20244370028     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Barleon B, Sozzani S, Zhou F, Weich HH, Mantovani A, and Marmé D (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor Flt-1. Blood 87:3336-3343.
2. Birkenhagen R, Schneppe B, Rock W, Wilting J, Weich HA, and McCarthy JEG (1996). Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor. Biochem J 316:703-707.
3. Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, and Lik-Shing Tsang M (1996). Heterodimers of placenta growth factor/vascular endothelial growth factor: Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 271:3154-3162.
4. Clauss M, Weich H, Breier G, Knies U, Röckl W, Waltenberger J, and Risau W (1996). The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J Biol Chem 271:17629-17634.
5. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dowker SK, Sims JE, and Mantovani A (1993). Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science (Washington DC) 261:472-475.
6. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, and Thomas KA (1990). Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632.
7. Connolly DT, Heuvelman D, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber R, and Feder J (1989a). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478.
8. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel NR, Haymore BL, Leimgruber R, and Feder J (1989b). Human vascular permeability factor: Isolation from U937 cells. J Biol Chem 264:20017-20024.
9. DeVries C, Escobedo JA, Ueno H, Houck K, Ferrara N, and Williams LT (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC) 255:989-991.
10. DiPalma T, Tucci M, Russo G, Maglione D, Lago CT, Romano A, Della Valle G, De Gregorio L, Dragani TA, Viglietto G, and Persico MG (1996). The placenta growth factor gene of the mouse. Mamm Genome 7:6-12.
11. DiSalvo J, Bayne ML, Conn G, Kwock PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, and Thomas KA (1995). Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer. J Biol Chem 270:7717-7723.
12. Ferrara N and Henzel WJ (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
13. Ferrara N, Keith AH, Jakeman LB, Winer J, and Leung DW (1991). The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211-218.
14. Folkman J (1995). Clinical application of research on angiogenesis. N Engl J Med 333:1757-1763.
15. Folkman J and Shing Y (1992). Angiogenesis. J Biol Chem 267:10931-10934.
16. Gimbrone MA, Cotran RS, and Folkman J (1974). Human vascular endothelial cells in culture. J Cell Biol 60:673-684.
17. Gospodarowicz D, Abraham JA, and Schilling J (1989). Isolation and characterization of a vascular endothelial mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86:7311-7315.
18. Hauser S and Weich HA (1993). A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9:259-268.
19. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, and Connolly DT (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC) 246:1309-1312.
20. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, and Ferrara N (1996). Identification of vascular endothelial growth factor determinants for binding KDR and Flt-1 receptors: Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 271:5638-5646.
21. Maglione D, Guerriero V, Rambaldi M, Russo G, and Persico MG (1993a). Translation of the placenta growth factor mRNA is severely affected by a small open reading frame localized in the 5′ untranslated region. Growth Factors 8:141-152.
22. Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei KJ, Chou JY, and Persico MG (1993b). Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14. Oncogene 8:925-931.
23. Maglione D, Guerriero V, Viglietto G, Risau W, Delli-Bovi P, and Persico MG (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
24. Olivo M, Bhardway R, Schulze-Osthoff K, Sorg C, Jurgen-Jacob H, and Flamme l (1992). A comparative study on the effects of tumor necrosis factor- (TNF-), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anat Rec 234:105-115.
25. Park JE, Chen HH, Winer J, Houck KA, and Ferrara N (1994). Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to FIk-1/KDR. J Biol Chem 269: 25646-25654.
26. Plouet J, Schilling J, and Gospodarowicz D (1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO (Eur Mol Biol Organ) J 8:3801-3806.
27. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, and Presta M (1995). Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 170:39-49.
28. Sawano A, Takahashi T, Yamaguchi S, Aonuma M, and Shibuya M (1996). Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213-221.
29. Schelling ME, Meininger CJ, Hawker JR, and Granger HJ (1988). Venular endothelial cells from bovine heart. Am J Physiol 254:H1211-H1217.
30. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS, and Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC) 219:983-985.
31. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, and Sato M (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (Flt) closely related to the fms family. Oncogene 5:519-524.
32. Soker S, Fidder H, Neufeld G, and Klagsbrun M (1996). Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF 165 via its exon 7-encoded domain. J Biol Chem 271:5761-5767.
33. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, and Terada M (1994). Markedly increased amount of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233-4237.
34. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, and Shows TB (1991). Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677-1683.
35. Terman BI, Khandke L, Dougher-Vermazan M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, and Eisinger M (1994). VEGF receptor subtypes KDR and Flt-1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11:187-195.
36. Tisher E, Mitchel R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, and Abraham JA (1991). The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11974-11984.
37. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Fusco A, and Persico MG (1995). Upregulation of vascular endothelial growth factor (VEGF) and down-regulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11:1569-1579.
38. Viglietto G, Romano A, Maglione D, Rambaldi M, Paoletti I, Lago CT, Califano D, Monaco C, Mineo A, Santelli G, Manzo G, Botti G, Chiappetta G and Persico MG (1996). Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta growth factor. Oncogene 13:577-587.
39. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, and Halmesmäki E (1997). Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56:489-494.
40. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, and Heldin C-H (1994). Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
41. Ziche M, Alessandri G, and Gullino PM (1989). Gangliosides promote the angiogenic response. Lab Invest 61:629-634.
42. Ziche M, Jones J, and Gullino PM (1982). Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 69:475-482.
43. Ziche M, Morbidelli L, Geppetti P, Maggi C, and Dolara P (1991). Substance P induces migration of capillary endothelial cells: a novel NK-1 receptor mediated activity. Life Sci 84:PL7-PL11.
44. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi C, Geppetti P, and Ledda F (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036-2044.